All News
Croda begins building North America HQ
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/Croda.jpg?itok=vCGsB4T5)
Croda begins building North America HQ
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/COVID%2520deals.jpg?itok=pMMcYhba)
More CDMOs in COVID-19 deals
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/Kodak.jpg?itok=C4KnAR8k)
Kodak enters pharma with government loan
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/Lonza%2520building.png?itok=D56XjxFd)
Pharma continues to drive Lonza growth
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/PIC.jpg?itok=zmAkTbs4)
PIC Regulation sees 22 substances added
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/David%2520Dunn%2520pic_2.jpg?itok=AOJSdata)
Digital intelligence: The chemical industry’s best counter to rising risk & uncertainty?
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/Lanxess_0.jpg?itok=rX_AkGSi)
Lanxess realigns in water treatment
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/Azelis.jpg?itok=VrZC6zSJ)
Azelis enters Israel with Orklia buy
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/Cefic.jpg?itok=eSc4icjf)
CEFIC calls for EU recovery plan
Andrew Warmington
![](/sites/default/files/styles/article_thumbnail/public/articles/CordenPharma.jpg?itok=J9E-hB9P)
CordenPharma in peptide expansion
Andrew Warmington